Understanding the local actions of lipids in bone physiology

被引:99
作者
During, Alexandrine [1 ]
Penel, Guillaume [1 ]
Hardouin, Pierre [1 ,2 ]
机构
[1] Univ Lille 2, Fac Chirurg Dent, Lab Physiopathol Malad Osseuses Inflammatoires PM, EA4490, Lille, France
[2] Univ ULCO, EA4490, Lab Physiopathol Malad Osseuses Inflammatoires PM, Boulogne Sur Mer, France
关键词
FATTY-ACID-COMPOSITION; CONJUGATED LINOLEIC-ACID; NEUTRAL SPHINGOMYELINASE 2; LYSOPHOSPHATIDIC ACID; OSTEOBLAST DIFFERENTIATION; CANNABINOID RECEPTOR; SPHINGOSINE; 1-PHOSPHATE; MATRIX VESICLES; MINERAL DENSITY; OSTEOCLAST DIFFERENTIATION;
D O I
10.1016/j.plipres.2015.06.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adult skeleton is a metabolically active organ system that undergoes continuous remodeling to remove old and/or stressed bone (resorption) and replace it with new bone (formation) in order to maintain a constant bone mass and preserve bone strength from micro-damage accumulation. In that remodeling process, cellular balances - adipocytogenesis/osteoblastogenesis and osteoblastogenesis/os teoclastogenesis - are critical and tightly controlled by many factors, including lipids as discussed in the present review. Interest in the bone lipid area has increased as a result of in vivo evidences indicating a reciprocal relationship between bone mass and marrow adiposity. Lipids in bones are usually assumed to be present only in the bone marrow. However, the mineralized bone tissue itself also contains small amounts of lipids which might play an important role in bone physiology. Fatty acids, cholesterol, phospholipids and several endogenous metabolites (i.e., prostaglandins, oxysterols) have been purported to act on bone cell survival and functions, the bone mineralization process, and critical signaling pathways. Thus, they can be regarded as regulatory molecules important in bone health. Recently, several specific lipids derived from membrane phospholipids (i.e., sphingosine-l-phosphate, lysophosphatidic acid and different fatty acid amides) have emerged as important mediators in bone physiology and the number of such molecules will probably increase in the near future. The present paper reviews the current knowledge about: (1) bone lipid composition in both bone marrow and mineralized tissue compartments, and (2) local actions of lipids on bone physiology in relation to their metabolism. Understanding the roles of lipids in bone is essential to knowing how an imbalance in their signaling pathways might contribute to bone pathologies, such as osteoporosis. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:126 / 146
页数:21
相关论文
共 233 条
[1]  
Ahn Seong Hee, 2013, J Bone Metab, V20, P61, DOI 10.11005/jbm.2013.20.2.61
[2]  
Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3
[3]   FATTY-ACID COMPOSITION AND ARACHIDONIC-ACID CONCENTRATIONS IN ALVEOLAR BONE OF RATS FED DIETS WITH DIFFERENT LIPIDS [J].
ALAM, SQ ;
KOKKINOS, PP ;
ALAM, BS .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (05) :330-332
[4]   The role of matrix vesicles in growth plate development and biomineralization [J].
Anderson, HC ;
Garimella, R ;
Tague, SE .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :822-837
[5]   A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse [J].
Aubin, I ;
Adams, CP ;
Opsahl, S ;
Septier, D ;
Bishop, CE ;
Auge, N ;
Salvayre, R ;
Negre-Salvayre, A ;
Goldberg, M ;
Guénet, JL ;
Poirier, C .
NATURE GENETICS, 2005, 37 (08) :803-805
[6]   Endocannabinoids and the regulation of bone metabolism [J].
Bab, I. ;
Ofek, O. ;
Tam, J. ;
Rehnelt, J. ;
Zimmer, A. .
JOURNAL OF NEUROENDOCRINOLOGY, 2008, 20 :69-74
[7]   Cannabinoid receptors and the regulation of bone mass [J].
Bab, I. ;
Zimmer, A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) :182-188
[8]   WNT signaling in bone homeostasis and disease: from human mutations to treatments [J].
Baron, Roland ;
Kneissel, Michaela .
NATURE MEDICINE, 2013, 19 (02) :179-192
[9]  
BERESFORD JN, 1992, J CELL SCI, V102, P341
[10]   Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase [J].
Bergstrom, JD ;
Bostedor, RG ;
Masarachia, PJ ;
Reszka, AA ;
Rodan, G .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 373 (01) :231-241